PMID- 25271054 OWN - NLM STAT- MEDLINE DCOM- 20151026 LR - 20211021 IS - 1535-3907 (Electronic) IS - 1535-3893 (Print) IS - 1535-3893 (Linking) VI - 13 IP - 12 DP - 2014 Dec 5 TI - In-depth quantitative proteomic analysis of de novo protein synthesis induced by brain-derived neurotrophic factor. PG - 5707-14 LID - 10.1021/pr5006982 [doi] AB - Measuring the synthesis of new proteins in the context of a much greater number of pre-existing proteins can be difficult. To overcome this obstacle, bioorthogonal noncanonical amino acid tagging (BONCAT) can be combined with stable isotope labeling by amino acid in cell culture (SILAC) for comparative proteomic analysis of de novo protein synthesis (BONLAC). In the present study, we show that alkyne resin-based isolation of l-azidohomoalanine (AHA)-labeled proteins using azide/alkyne cycloaddition minimizes contamination from pre-existing proteins. Using this approach, we isolated and identified 7414 BONCAT-labeled proteins. The nascent proteome isolated by BONCAT was very similar to the steady-state proteome, although transcription factors were highly enriched by BONCAT. About 30% of the methionine residues were replaced by AHA in our BONCAT samples, which allowed for identification of methionine-containing peptides. There was no bias against low-methionine proteins by BONCAT at the proteome level. When we applied the BONLAC approach to screen for brain-derived neurotrophic factor (BDNF)-induced protein synthesis, 53 proteins were found to be significantly changed 2 h after BDNF stimulation. Our study demonstrated that the newly synthesized proteome, even after a short period of stimulation, can be efficiently isolated by BONCAT and analyzed to a depth that is similar to that of the steady-state proteome. FAU - Zhang, Guoan AU - Zhang G AD - Department of Biochemistry and Molecular Pharmacology, double daggerDepartments of Cell Biology, Physiology, and Neuroscience and Psychiatry, Kimmel Center for Biology and Medicine at the Skirball Institute, New York University School of Medicine , New York, New York 10016, United States. FAU - Bowling, Heather AU - Bowling H FAU - Hom, Nancy AU - Hom N FAU - Kirshenbaum, Kent AU - Kirshenbaum K FAU - Klann, Eric AU - Klann E FAU - Chao, Moses V AU - Chao MV FAU - Neubert, Thomas A AU - Neubert TA LA - eng GR - P01 HD023315/HD/NICHD NIH HHS/United States GR - T32 MH019524/MH/NIMH NIH HHS/United States GR - R01 NS047384/NS/NINDS NIH HHS/United States GR - R37 NS034007/NS/NINDS NIH HHS/United States GR - R01 HD23315/HD/NICHD NIH HHS/United States GR - R01 AG025970/AG/NIA NIH HHS/United States GR - R01 NS21072/NS/NINDS NIH HHS/United States GR - R01 NS034007/NS/NINDS NIH HHS/United States GR - R01 NS021072/NS/NINDS NIH HHS/United States GR - P30 NS050276/NS/NINDS NIH HHS/United States GR - T32 MH019524-20/MH/NIMH NIH HHS/United States GR - S10 RR027990/RR/NCRR NIH HHS/United States GR - R56 NS021072/NS/NINDS NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, U.S. Gov't, Non-P.H.S. DEP - 20141013 PL - United States TA - J Proteome Res JT - Journal of proteome research JID - 101128775 RN - 0 (Brain-Derived Neurotrophic Factor) RN - 0 (Proteome) RN - 0 (azidohomoalanine) RN - OF5P57N2ZX (Alanine) SB - IM MH - Alanine/analogs & derivatives/chemistry MH - Brain-Derived Neurotrophic Factor/*pharmacology MH - Chromatography, Liquid MH - HEK293 Cells MH - Humans MH - Mass Spectrometry MH - Protein Biosynthesis/*drug effects MH - Proteome/*analysis/chemistry/metabolism MH - Proteomics/*methods MH - Reproducibility of Results PMC - PMC4261974 OTO - NOTNLM OT - BDNF OT - BONCAT OT - mass spectrometry OT - proteomics OT - pulsed SILAC OT - translation EDAT- 2014/10/02 06:00 MHDA- 2015/10/27 06:00 PMCR- 2015/10/01 CRDT- 2014/10/02 06:00 PHST- 2014/10/02 06:00 [entrez] PHST- 2014/10/02 06:00 [pubmed] PHST- 2015/10/27 06:00 [medline] PHST- 2015/10/01 00:00 [pmc-release] AID - 10.1021/pr5006982 [doi] PST - ppublish SO - J Proteome Res. 2014 Dec 5;13(12):5707-14. doi: 10.1021/pr5006982. Epub 2014 Oct 13.